ASPEGIC

This brand name is authorized in Estonia, France, Netherlands, Tunisia, UK.

Active ingredients

The drug ASPEGIC contains one active pharmaceutical ingredient (API):

1
UNII 2JJ274J145 - ASPIRIN DL-LYSINE
 

Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.

 
Read more about Acetylsalicylic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N02BA01 Acetylsalicylic acid N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives
Discover more medicines within N02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1781759, 1821989, 1822979
FR Base de données publique des médicaments 61162942, 63936571, 66311831, 66769394, 68300762, 68852682
GB Medicines & Healthcare Products Regulatory Agency 112574, 112575, 112580, 112581
NL Z-Index G-Standaard 12103918
NL Z-Index G-Standaard, PRK 2895
TN Direction de la Pharmacie et du Médicament 6460016, 6480011, 6480016H, 9103961, 9103962, 9103963, 9103964, 92630110, 92630111, 92630112, 9263012, 9263013, 9263014, 9263019

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.